Anlon Healthcare Ltd vs Tanfac Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tanfac Industries Ltd changed from 13.9 on March 2021 to 32.8 on March 2025 . This represents a CAGR of 18.73% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tanfac Industries Ltd changed from ₹ 243.69 crore on March 2021 to ₹ 2891 crore on March 2025 . This represents a CAGR of 64.00% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Tanfac Industries Ltd for the Dec '25 is ₹ 173.57 crore as compare to the Sep '25 revenue of ₹ 169.31 crore. This represent the growth of 2.52% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Tanfac Industries Ltd for the Dec '25 is ₹ 26.15 crore as compare to the Sep '25 ebitda of ₹ 27.49 crore. This represent the decline of -4.87% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Tanfac Industries Ltd changed from ₹ 11.29 crore to ₹ 15.57 crore over 7 quarters. This represents a CAGR of 20.16% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Tanfac Industries Ltd changed from 16.86 % on March 2022 to 10.19 % on March 2025 . This represents a CAGR of -11.83% over 4 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Tanfac Industries Ltd

Tanfac Industries Limited, is a Joint Venture Company promoted by Anupam Rasayan India Limited, previously by Aditya Birla Group and the Tamil Nadu Industrial Development Corporation Limited (TIDCO).
Incorporated in 1972, the Company is India's largest supplier of fluorine chemicals.
The Company commenced production in March 1985 with 100% capacity utilisation. The company's diversification scheme for the manufacture of Organo Fluorine Chemicals was completed in 1998-99.
The Organo Fluorine Chemicals viz. 2,4, Dichloro fluorobenzene, Acetophenone etc., used as intermediate chemicals in the manufacture of new generation antibiotics (bulk drugs) called Ciprofloxacin, Enrofloxacin etc.
The technology was sourced from Dalian F Chem, China. In 2000-01 the operations of the Company's new project for manufacture of DFCA remained suspended as it is uneconomical to operate the plant at the current depressed market price.

FAQs for the comparison of Anlon Healthcare Ltd and Tanfac Industries Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Tanfac Industries Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Tanfac Industries Ltd is 3,871 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Tanfac Industries Ltd?

The stock performance of Anlon Healthcare Ltd and Tanfac Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Tanfac Industries Ltd?

As of March 23, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Tanfac Industries Ltd stock price is INR ₹1940.8.

How do dividend payouts of Anlon Healthcare Ltd and Tanfac Industries Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Tanfac Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.